Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 61 articles:
HTML format
Text format



Single Articles


    March 2017
  1. OMINO R, Mittal S, Kramer JR, Chayanupatkul M, et al
    The Validity of HCC Diagnosis Codes in Chronic Hepatitis B Patients in the Veterans Health Administration.
    Dig Dis Sci. 2017 Mar 7. doi: 10.1007/s10620-017-4503.
    PubMed     Text format     Abstract available


    February 2017
  2. AHN J, Liu B, Bhuket T, Wong RJ, et al
    Race/Ethnicity-Specific Outcomes Among Chronic Hepatitis C Virus Patients Listed for Liver Transplantation.
    Dig Dis Sci. 2017 Feb 6. doi: 10.1007/s10620-017-4469.
    PubMed     Text format     Abstract available


    January 2017
  3. SHALIMAR, Kedia S, Gunjan D, Sonika U, et al
    Acute Liver Failure Due to Hepatitis E Virus Infection Is Associated with Better Survival than Other Etiologies in Indian Patients.
    Dig Dis Sci. 2017 Jan 27. doi: 10.1007/s10620-017-4461.
    PubMed     Text format     Abstract available


  4. RIVEIRO-BARCIELA M, Tabernero D, Calleja JL, Lens S, et al
    Effectiveness and Safety of Entecavir or Tenofovir in a Spanish Cohort of Chronic Hepatitis B Patients: Validation of the Page-B Score to Predict Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jan 11. doi: 10.1007/s10620-017-4448.
    PubMed     Text format     Abstract available


  5. AGORAMOORTHY G
    India Needs Effective Surveillance to Control Hepatitis C.
    Dig Dis Sci. 2017 Jan 3. doi: 10.1007/s10620-016-4436.
    PubMed     Text format    


    December 2016
  6. KIM EJ, Yeon JE, Kwon OS, Lee HN, et al
    Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4431.
    PubMed     Text format     Abstract available


    October 2016
  7. BECK KR, Kim N, Khalili M
    Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  8. ASSIS DN, Takahashi H, Leng L, Zeniya M, et al
    A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    September 2016
  9. NATARAJAN Y, White DL, El-Serag HB, Ramsey D, et al
    Role of Non-hepatic Medical Comorbidity and Functional Limitations in Predicting Mortality in Patients with HCV.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  10. HE QF, Zhang QF, Zhang DZ
    Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  11. FOX R
    Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    August 2016
  12. FOSTER MA, Xing J, Moorman AC, Boscarino J, et al
    Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    July 2016
  13. WEILER-NORMANN C, Lohse AW
    Nonalcoholic Fatty Liver Disease in Patients with Autoimmune Hepatitis: Further Reason for Teeth GNASHing?
    Dig Dis Sci. 2016.
    PubMed     Text format    


  14. MONTANO-LOZA AJ, Thandassery RB, Czaja AJ
    Targeting Hepatic Fibrosis in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  15. CZAJA AJ
    Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    June 2016
  16. DE LUCA-JOHNSON J, Wangensteen KJ, Hanson J, Krawitt E, et al
    Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    May 2016
  17. CHAK EW, Sarkar S, Bowlus C
    Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  18. MOORMAN AC, Tong X, Spradling PR, Rupp LB, et al
    Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS).
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    April 2016
  19. CHOLANKERIL G, Perumpail RB, Hu M, Skowron G, et al
    Chronic Hepatitis B Is Associated with Higher Inpatient Resource Utilization and Mortality Versus Chronic Hepatitis C.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  20. COZEN ML, Ryan JC, Shen H, Cheung R, et al
    Improved Survival Among all Interferon-alpha-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  21. JHA LK, Gilbert J
    Treatment of Dual Genotype Chronic Hepatitis C: Case Series.
    Dig Dis Sci. 2016.
    PubMed     Text format    


    March 2016
  22. BURMAN BE, Bacchetti P, Khalili M
    Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  23. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  24. THOMSON M, Konerman MA, Choxi H, Lok AS, et al
    Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


    February 2016
  25. PATIDAR KR, Bajaj JS
    Tired of Hepatitis B?
    Dig Dis Sci. 2016.
    PubMed     Text format    


    January 2016
  26. EVON DM, Wahed AS, Johnson G, Khalili M, et al
    Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  27. MARCELLIN P, Zoulim F, Hezode C, Causse X, et al
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  28. RUBIN JN, Te HS
    Refractory Autoimmune Hepatitis: Beyond Standard Therapy.
    Dig Dis Sci. 2016.
    PubMed     Text format     Abstract available


  29. FLEMMING JA, Saxena V, Shen H, Terrault NA, et al
    Facility- and Patient-Level Factors Associated with Esophageal Variceal Screening in the USA.
    Dig Dis Sci. 2016;61:62-9.
    PubMed     Text format     Abstract available


    December 2015
  30. DYAL HK, Aguilar M, Bartos G, Holt EW, et al
    Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  31. DOU CY, Fan YC, Cao CJ, Yang Y, et al
    Sera DNA Methylation of CDH1, DNMT3b and ESR1 Promoters as Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  32. URIBE LA, Nguyen N, Kim L, Trinh HN, et al
    Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2015
  33. PETERSEN J, Heyne R, Mauss S, Schlaak J, et al
    Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  34. ROGAL SS, Yan P, Rimland D, Re VL 3rd, et al
    Incidence and Progression of Chronic Kidney Disease After Hepatitis C Seroconversion: Results from ERCHIVES.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    October 2015
  35. MAIWALL R, Chandel SS, Wani Z, Kumar S, et al
    SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  36. JAYASEKERA CR, Perumpail RB, Chao DT, Pham EA, et al
    Task-Shifting: An Approach to Decentralized Hepatitis C Treatment in Medically Underserved Areas.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  37. GARCIA-COMPEAN D, Gonzalez-Gonzalez JA, Lavalle-Gonzalez FJ, Gonzalez-Moreno EI, et al
    Current Concepts in Diabetes Mellitus and Chronic Liver Disease: Clinical Outcomes, Hepatitis C Virus Association, and Therapy.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    September 2015
  38. GOLDHABER-FIEBERT JD
    New, Expensive Treatments for Chronic Hepatitis C: Insuring Good Outcomes?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    August 2015
  39. COLOM STEELE D, Mojtahed A, Samedi V, Alcorn J, et al
    "Ferritin Out" a Cause of Acute Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


    July 2015
  40. KIM HJ, Sinn DH, Kim NJ, Kim JH, et al
    Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  41. MEILLIER A, Patel S, Al-Osaimi AM
    Readability of Healthcare Literature for Hepatitis B and C.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  42. FABRIZI F, Verdesca S, Messa P, Martin P, et al
    Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  43. RAVI S, Shoreibah M, Raff E, Bloomer J, et al
    Autoimmune Markers Do Not Impact Clinical Presentation or Natural History of Steatohepatitis-Related Liver Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  44. FONG TL, Tien A, Jo KJ, Chu D, et al
    Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  45. DYAL HK, Aguilar M, Bhuket T, Liu B, et al
    Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    June 2015
  46. CASADO JL, Esteban MA, Banon S, Moreno A, et al
    Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  47. LIN CW, Huang XL, Liu HL, Wang Y, et al
    Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  48. PERUMPAIL RB, Wong RJ, Pham EA, Higgins JP, et al
    A New Standard of Care? Standard Dose Sofosbuvir in an HCV-Infected Liver Transplant Recipient Undergoing Hemodialysis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


  49. FEENEY ER, Chung RT
    The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C.
    Dig Dis Sci. 2015.
    PubMed     Text format    


    May 2015
  50. SAAB S, Rheem J, Sundaram V
    Hepatitis C Infection in the Elderly.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  51. CZAJA AJ
    Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  52. DEFILIPPIS EM, Kumar S
    Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  53. ZAMPINO R, Coppola N, Cirillo G, Boemio A, et al
    Patatin-Like Phospholipase Domain-Containing 3 I148M Variant Is Associated with Liver Steatosis and Fat Distribution in Chronic Hepatitis B.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  54. STEPANOVA M, Younossi ZM
    Interferon-Free Regimens for Chronic Hepatitis C: Barriers Due to Treatment Candidacy and Insurance Coverage.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  55. YU F, Zhou G, Li G, Chen B, et al
    Serum miR-181b Is Correlated with Hepatitis B Virus Replication and Disease Progression in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


  56. ALATRAKCHI N
    Bregs in Chronic HBV: Is It Time for Bragging Rights?
    Dig Dis Sci. 2015;60:1115-7.
    PubMed     Text format    


    April 2015
  57. EFE C, Bogdanos DP
    Reply: To PMID 25002309.
    Dig Dis Sci. 2015;60:1107-8.
    PubMed     Text format    


    February 2015
  58. KHIRFAN K, Hanson J, Alcorn J
    Portal Hypertension in Alcoholic Liver Disease: Can It Be Fixed?
    Dig Dis Sci. 2015.
    PubMed     Text format    


    January 2015
  59. WANG C, Hann HW, Hann RS, Wan S, et al
    Circulating Mitochondrial DNA Content Associated with the Risk of Liver Cirrhosis: A Nested Case-Control Study.
    Dig Dis Sci. 2015.
    PubMed     Text format     Abstract available


    November 2014
  60. ROGAL SS, Bielefeldt K, Wasan AD, Szigethy E, et al
    Fibromyalgia Symptoms and Cirrhosis.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


  61. STINE JG, Intagliata N, Shah NL, Argo CK, et al
    Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis.
    Dig Dis Sci. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: